2018
DOI: 10.1111/cod.12878
|View full text |Cite
|
Sign up to set email alerts
|

First case report of acute generalized exanthematous pustulosis (AGEP) caused by gadolinium confirmed by patch testing

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
10
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(10 citation statements)
references
References 9 publications
0
10
0
Order By: Relevance
“… * Positivity criteria according to ENDA's guidelines . The rest of the studies do not specify the positivity criteria, except ( 30 ) that follows the Contact Dermatitis Research Group Scoring system recommendations and ( 31 ) that follow the European Society of Contact Dermatitis recommendations .…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“… * Positivity criteria according to ENDA's guidelines . The rest of the studies do not specify the positivity criteria, except ( 30 ) that follows the Contact Dermatitis Research Group Scoring system recommendations and ( 31 ) that follow the European Society of Contact Dermatitis recommendations .…”
Section: Resultsmentioning
confidence: 99%
“…One case ( 31 ) involved an acute generalized exanthematous pustulosis (AGEP) due to gadobutrol, with PTs yielding positive results to gadobutrol on days 2 and 4 and negative results to gadoterate meglumine. DPTs were not performed.…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, the patient received several drugs in addition to gadobutrol and no allergy work-up were performed. The same year, a case of acute generalized exanthematous pustulosis (AGEP) following GBCA injection was also described [8]. In this case, the injected GBCA was unknown.…”
mentioning
confidence: 83%
“…19 Nonimmediate hypersensitivity reactions to GBCM are extremely rare, but AGEP has been reported. 20 An important nonallergic late reaction to GBCM, especially in patients with impaired kidney function, is nephrogenic systemic fibrosis, which causes fibrosis mostly of the skin and subcutaneous tissues. However, internal organs, skeletal muscles, and joints can be involved, and fatalities have been reported.…”
Section: Clinical Findings In Nihrmentioning
confidence: 99%